Tag: rare blood cancer

FDA approves pacritinib (Vonjo), a new treatment for myelofibrosis in adults with low platelet counts, targeting abnormal bone marrow signaling.

FDA approves Carvykti, a groundbreaking CAR-T therapy for relapsed/refractory multiple myeloma, offering personalized immune-cell treatment for blood cancer pat

Navigate the complexities of myelofibrosis and anemia with this patient roadmap. Learn strategies to manage fatigue and find stability in your rare disease jour

The FDA has approved the first new essential thrombocythemia drug in 30 years. Learn how Besremi works and offers a fresh treatment option for patients.